|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-5-22
|
|
pubmed:abstractText |
Treatment by octreotide has been suggested in medullary thyroid carcinoma patients with post-surgery metastases. The purpose of this study was to evaluate if the tumoral regression could be improved by a high dose and by prolonged octreotide treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
183-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1568350-Adult,
pubmed-meshheading:1568350-Calcitonin,
pubmed-meshheading:1568350-Carcinoma,
pubmed-meshheading:1568350-Drug Administration Schedule,
pubmed-meshheading:1568350-Female,
pubmed-meshheading:1568350-Humans,
pubmed-meshheading:1568350-Infusion Pumps, Implantable,
pubmed-meshheading:1568350-Male,
pubmed-meshheading:1568350-Middle Aged,
pubmed-meshheading:1568350-Neoplasm Staging,
pubmed-meshheading:1568350-Octreotide,
pubmed-meshheading:1568350-Thyroid Neoplasms,
pubmed-meshheading:1568350-Thyroidectomy,
pubmed-meshheading:1568350-Time Factors
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.
|
|
pubmed:affiliation |
Département d'endocrinologie, Hopital Avicenne, Bobigny, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
